Moderna
MRNA • NASDAQ
Moderna is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Stéphane Bancel, with a market cap of $19.7B.
CEOStéphane Bancel
Next Earnings
Upcoming earnings announcement for Moderna
Date
Thursday, April 30, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$2.07
Revenue Estimate
$235.8M
Earnings History
Past 12 earnings reports for Moderna
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | Q4 2025 | -$2.11Est: -$2.60 | +18.8% | $678.0MEst: $638.9M | +6.1% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.51Est: -$2.17 | +76.5% | $1.0BEst: $866.0M | +17.3% | 10-Q |
| Aug 1, 2025 | Q2 2025 | -$2.13Est: -$2.98 | +28.5% | $142.0MEst: $119.0M | +19.3% | 10-Q |
| May 1, 2025 | Q1 2025 | -$2.52Est: -$3.18 | +20.8% | $108.0MEst: $115.3M | -6.3% | 10-Q |
| Feb 14, 2025 | Q4 2024 | -$2.91Est: -$2.68 | -8.6% | $966.0MEst: $942.8M | +2.5% | 10-K |
| Nov 7, 2024 | Q3 2024 | $0.03Est: -$1.90 | +101.6% | $1.9BEst: $1.3B | +49.0% | 10-Q |
| Aug 1, 2024 | Q2 2024 | -$3.33Est: -$3.39 | +1.8% | $241.0MEst: $132.2M | +82.3% | 10-Q |
| May 2, 2024 | Q1 2024 | -$3.07Est: -$3.35 | +8.4% | $167.0MEst: $91.0M | +83.5% | 10-Q |
| Feb 22, 2024 | Q4 2023 | $0.55Est: -$0.97 | +156.7% | $2.8BEst: $2.5B | +12.9% | 10-K |
| Nov 2, 2023 | Q3 2023 | -$9.53Est: -$1.93 | -393.8% | $1.8BEst: $1.4B | +30.8% | 10-Q |
| Aug 3, 2023 | Q2 2023 | -$3.62Est: -$3.84 | +5.7% | $344.0MEst: $290.7M | +18.3% | — |
| May 4, 2023 | Q1 2023 | $0.19Est: -$1.77 | +110.7% | $1.9BEst: $1.2B | +57.8% | — |